Free beta — full access, free until October 2026. No card, no auto-charge — paid plans are opt-in when they launch.
Company
TARO PHARMACEUTICAL INDUSTRIES LTD (0000906338)
Standardized SEC financial data for TARO PHARMACEUTICAL INDUSTRIES LTD — income statement, balance sheet, cash flow and 40+ ratios, available as a clean JSON API. CIK 0000906338 · Pharmaceutical Preparations.
Income statement
USD
FY2018
FY2019
FY2020
FY2021
FY2022
FY2023
Revenue
$661.9M
$669.9M
$644.8M
$549.0M
$561.3M
$573.0M
Cost of revenue
$198.4M
$224.2M
$245.0M
$252.3M
$268.2M
$304.6M
Gross profit
$463.5M
$445.7M
$399.7M
$296.7M
$293.1M
$268.3M
R&D expense
$70.4M
$63.2M
$59.8M
$60.2M
$54.5M
$52.2M
SG&A expense
$88.2M
$90.0M
$93.4M
$91.4M
$113.7M
$198.4M
Operating income
$303.0M
$296.2M
$246.5M
-$413.8M
$63.5M
$17.7M
EBITDA
$319.5M
$314.8M
$267.9M
-$390.1M
$89.4M
$49.8M
Pretax income
$292.4M
$356.9M
$298.0M
-$391.1M
$77.9M
$38.2M
Income tax
$82.0M
$74.7M
$53.5M
$9.7M
$19.6M
$12.8M
Net income
$211.2M
$281.8M
$244.2M
-$386.7M
$58.3M
$25.4M
EPS (diluted)
$5.26
—
—
$-10.12
$1.55
$0.68
Standardized from TARO PHARMACEUTICAL INDUSTRIES LTD's SEC filings — per-share figures split-adjusted. Full history via the API.